Phase I/II Clinical Trial of UX-DA003 Injection for the Treatment of Patients With Parkinson's Disease
Clinical trial NCT07733349 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07733349
- Sponsor
- Shanghai UniXell Biotechnology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-03
- Primary completion
- 2029-08-31
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.